CELF1 and myotonic dystrophy type 1: While CELF1 has been best characterized in the context of myotonic dystrophy type 1 (DM1) models (17, 18), a growing body of work has associated CELF1 overexpression with cancer proliferation, migration, invasion, and overall tumor aggressivity in multiple cancer models (19, 20, 21, 22).